SlideShare une entreprise Scribd logo
1  sur  85
Télécharger pour lire hors ligne
HIBBs is a program of the Global
Health Informatics Partnership
PRESENTED BY: - NEHA BHARTI
M.SC (N) MEDICAL SURGICAL NURSING
NURSING TUTOR
SMVDCON, KAKRYAL
ACUTE RENAL FAILURE
RENAL FAILURE
 Renal failure or kidney failure (formerly
called renal insufficiency) is a situation in
which the kidneys fail to function
adequately.
 It is characterised by the reduction in
the excretory and regulatory functions of
the kidney.
 If the kidney function fails, the waste
products accumulate in the blood and
the body leading to a disruption in
endocrine and metabolic functions as
well as fluid, electrolyte, and acidbase
disturbances.
 Renal failure can be acute, with sudden
onset of symptoms, or chronic, occurring
gradually over time.
 Once renal failure occurs, it requires
immediate management and even then
prognosis is often not good unless
transplantation is done.
ACUTE RENAL FAILURE
 Acute kidney failure is
the sudden and
complete loss of the
ability of the kidneys to
remove waste.
 It occurs when the
kidneys stop working
over a period of hours,
days, or in some
cases, weeks.
Acute kidney failure a sudden decline in
renal function, usually marked by
 Decreased glomerular filtration rate (GFR),
 Increased concentrations of blood urea
nitrogen (BUN; azotemia) and creatinine;
 The urine output is less than 400 ml per
day (oliguria);
 Hyperkalemia (blood potassium level is
normally 3.6 to 5.2 millimoles per liter
(mmol/L)) and
 Sodium retention.
 Acute kidney failure is most common in
people who are already hospitalized/
particularly in Critically ill people who need
intensive care.
ETIOLOGY AND CATEGORIES OF
ACUTE RENAL FAILURE
RISK FACTORS
Acute kidney failure almost always occurs in
connection with another medical condition
or event. Conditions that increase risk of
acute kidney failure include:
 Being hospitalized, especially for a serious
condition that requires intensive care
 Advanced age
 Blockages in the blood vessels in arms
or legs (peripheral artery disease)
 Diabetes
 High blood pressure
 Heart failure
 Kidney diseases
 Liver disease
PATHOPHYSIOLOGY
In response to renal injury, there is
thought to be an increase in intra-
glomerular pressure with glomerular
hypertrophy, as the kidney attempts
to adapt to nephron loss to maintain
constant glomerular filtration
Failure of renal circulation and
glomerular or tubular dysfunction
Damaged tubules cannot conserve
sodium normally which activates
rennin angiotensin– aldosterone system
Pathogenesis of acute renal failure is not clear:
Sodium and fluid retention
which leads to edema
Reduced blood flow to
kidney due to renal
vasoconstriction
Sudden and complete loss of
kidney function
Oliguria
Increased serum creatinine, BUN
level and retention of other
metabolic waste
Increased circulatory overload
and sodium retention
ACUTE RENAL
FAILURE
PHASES Of
ACUTE RENAL FAILURE
1. Onset or Initiation Phase
 It marks the time from the onset of
injury till the death of a person. ARF
begins with the underlying clinical condition
leading to tubular necrosis, for example
haemorrhage, which reduces blood
volume.
 This period lasts from hours to days only
but can cause irreversible damage
2. Oliguric Phase
 This phase starts when urinary volume less
than 30 ml to 400 ml/ 24 hours. A
persistent decrease in GFR and tubular
necrosis characterizes this phase.
 This phase of acute renal failure lasts
for 7-14 days but does a lot of damage
to the walls and membranes of the
kidney.
 The period of oliguria accompanied by a
rise in the urea, creatinine, uric acid,
organic acid and intracellular cations
(potassium and magnesium).
3. Diuresis Phase
 Diuresis phase is marked by increased
urine secretion of more than 400 ml/
24 hours. Renal function of the kidney
improves quickly the fifteen to twenty five
days of this phase.
 The patient is closely monitored for
dehydration during this phase; if
dehydration occurs, the uremic symptoms
are likely to increase.
4. Recovery Phase
 It begins with the recovery of the tubular
function to such an extent that BUN
and serum creatinine stabilizes.
 Improvement in renal function may
continue over 3 to 12 months and
more nephrons regain function
CLINICAL MANIFESTATIONS
DARK COLORED
URINE
Foamy or bubbly
urine and getting
up at night to
urinate
 Skin and mucous membrane are dry
from dehydration
 Azotemia :- is a medical condition
characterized by abnormally high levels of
nitrogen-containing compounds (such as
urea, creatinine, various body waste
compounds, and other nitrogen-rich
compounds) in the blood.
 Oliguria or anuria: Less than 30cc
(30ml) an hour urine output despite
replacement.
 Edema or Fluid retention, causing
swelling in legs, ankles or feet
 Hypertension and Rapid heart rate
 Metabolic acidosis:- is a condition that
occurs when the body produces excessive
quantities of acid or when the kidneys are not
removing enough acid from the body.
 Anemia
 Increased susceptibility to secondary infection
 Fluid and electrolyte imbalance
 Gastrointestinal System: Anorexia,
nausea, vomiting, diarrhea or constipation,
dry mucous membrane, abdominal pain and
may have the odor of urine
DIAGNOSTIC EVALUATIONS
 Blood tests: elevated blood urea nitrogen
(BUN), serum creatinine, and potassium level
(hyperkalemia); decreased bicarbonate level,
hematocrit and hemoglobin levels; and low
blood pH.
 Levels of BUN and creatinine are high in
kidney failure. This is called azotemia.
 Electrolyte levels in the blood may be
abnormally high or low because of improper
filtering.
 Urine tests: Analyzing a sample of urine, a
procedure called urinalysis, may reveal
abnormalities that suggest kidney failure.
 The amount of urine excrete in one day
may help doctor determine the cause of
kidney failure.
 Urine studies shows proteinuria,
hematuria, and decreased specific
gravity.
 Urine chemistry shows decreased amount
of sodium (below 20 mEq/L) in urine
and high potassium level.
Imaging tests:
 The diagnosis of ARF is also supported by
ultrasonography, plain films of the
abdomen, KUB radiography, renal scan,
pyelography, computerized tomography.
Kidney Biopsy:
 In certain situations, doctor may
recommend a kidney biopsy to remove a
small sample of kidney tissue for laboratory
testing.
 To remove a sample of kidney tissue, doctor
may insert a thin needle through skin and
into kidney.
MANAGEMENT
 Treatment for acute kidney failure involves
identifying the illness or injury that originally
damaged kidneys.
 Once the cause is found, the goal of
treatment is to correct or treat the cause
of kidney failure, restore kidney function and
prevent fluid and waste from building up in
the body while the kidneys heal.
A. Pharmacologic Therapy
 Drugs are used to reduce the blood pressure
(antihypertensive); diuretics (drugs that
increase urine output) are used.
 Low dose dopamine (1-3g/kg) is often used
to dilate the renal arteries through stimulation
of dopaminergic receptors.
 Diuretic therapy with furosemide or mannitol
may be used for management of fluid volume
status.
 Calcium or glucose/insulin will be given
through a vein to help avoid dangerous
increases in blood potassium levels.
 Administer intravenous sodium
bicarbonate for more severe hyperkalemic
symptoms and for the correction of acidosis
and elevated phosphate level.
 Antibiotics may be needed to treat
associated infections (predominantly only
antibiotics excreted by the liver are used if
there is no liver disease (erythromycin,
azithromycin, chloramphenicol).
 Administer anticonvulsants
(levetiracetam) for seizures (excessive and
abnormal brain cell activity), antiemetics
(drugs that prevent vomiting) for nausea,
laxatives for constipation and vitamin
supplements
B. FLUID AND ELECTROLYTE
REPLACEMENT
 Intravenous solutions must be carefully
selected according to the patient’s fluid and
electrolyte status.
 Treat hyperkalemia (high potassium) with
insulin, calcium gluconate, Sodium
polystyrene sulfonate or dialysis.
 Replace lost fluids, such as water, blood, and
plasma, and restore blood flow to the kidneys
in cases of prerenal ARF caused by
dehydration or blood loss, for example,
kidney function may quickly return to
normal after fluid and blood levels are
corrected.
C. Nutritional Therapy
 Proper nutrition is crucial in the management
of acute renal failure. A high calorie diet
that’s low in protein, sodium and potassium is
usually prescribed to meet the metabolic
needs of patient in renal failure.
 Potassium intake is usually restricted to
40 to 60mEq/day and sodium is usually
restricted to 2g/day.
 Low-potassium foods include apples,
cabbage, carrots, green beans, grapes and
strawberries.
D. Dialysis
NURSING MANAGEMENT
 ASSESSMENT:-
NURSING DIAGNOSIS
1. Fluid volume excess related to decreased
glomerular filtration rate, decreased urine
output and sodium retention as evidenced
by weight gain, edema, intake greater than
output, changes in urine specific gravity,
jugular vein distention and shortness of
breath; orthopnea.
2. Risk for decreased cardiac output related to
fluid overload, fluid shifts, fluid deficit
(excessive losses), and electrolyte imbalance
(potassium, calcium),severe acidosis.
3. Imbalanced Nutrition: Less Than Body
Requirements related to protein catabolism;
dietary restrictions to reduce nitrogenous
waste products, increased metabolic needs,
anorexia, nausea, vomiting, dietary restriction
and malnutrition associated with renal failure
as evidenced by weakness and weight
changes.
4. Risk for infection related to depression of
immunologic defenses (secondary to uremia),
invasive procedures/ devices and changes in
dietary intake/malnutrition
5. Risk for deficient fluid volume related to
excessive loss of fluid (diuretic phase of ARF,
with rising urinary volume and delayed return
of tubular re- absorption capabilities)
CHRONIC RENAL FAILURE
Chronic kidney disease (CKD), also
known as chronic renal disease, is a
rapidly progressive deterioration or loss
of renal function in which the body’s
ability to maintain metabolic and fluid
and electrolyte balance fails, resulting in
uremia or azotemia over a period of
months or years.
This is characterized by a slow, insidious,
and irreversible impairment of renal
excretory and regulatory function.
The final stage of chronic kidney disease
is called endstage renal disease (ESRD).
Chronic glomerulonephritis (inflammation of
the glomeruli)
Long term infection such as chronic pyelo-
nephritis, and tuberculosis
Nephrotoxic agents: Long term aminoglycoside
therapy
Autoimmune disorders (such as systemic lupus
erythematosus and scleroderma)
Kidney stones and infection
Due to any etiological factors renal
functions declines
Nephron damage is progressive;
damage nephron cannot function and do
not recover
Decreased GFR
Remaining nephrons undergo changes
to compensate for those damaged
nephrons
Compensatory excretion
continues as GFR diminishes
Filtration of more concentrated blood
by the remaining nephrons
Damage of nephron results in
hypertrophy
Urine may contain abnormal
amount of protein, RBCs, WBCs
Increased serum creatinine,
BUN, urea and other
nitrogenous waste in blood
Further, damage of nephron
80-90%
CHRONIC RENAL
FAILURE
1. REDUCED RENAL RESERVE:
Chronic renal failure is a progressive
disease process.In the early,or silent,
stage the patient is usually without
symptoms,even though up to 50
percent of nephron function may have
been lost.This stage is often not
diagnosed.
2. RENAL INSUFFICIENCY:
 The renal insufficiency stage occurs when
the patient has lost 75 percent of nephron
function and some signs of mild renal failure
are present.
 Anemia and the inability to concentrate
urine may occur. The BUN and creatinine
levels are slightly elevated. These patients
are at risk for further damage caused by
infection,dehydration, drugs,etc.
The goal of care is to prevent further
damage if possible by good control of
blood sugar levels and blood pressure.
3. END-STAGE RENAL DISEASE:
 ESRD occurs when 90 percent of the nephrons are lost.
Patients at this stage experience chronic and persistent
abnormal kidney function. The BUN and creatinine
levels are always elevated.
 These patients may make urine but not filter out the
waste products, or urine production may cease.
Dialysis or a kidney transplant is required to survive.
Uremia (urea in the blood) is present in chronic renal
failure.
Patients eventually develop problems in
all body systems.If left untreated,the
patient with uremia dies,often within
weeks
Uremic symptoms can affect every organ
system, most noticeably the following:
NEUROLOGICAL SYSTEM:
 Cognitive impairment,
 Personality change,
 Asterixis ( (tremer) motor disturbance that
affects groups of muscles), seizures (rare),
confusion,
 Inability to concentrate, disorientation,
 Burning of soles of feet
GASTROINTESTINAL SYSTEM –
Nausea,vomiting,
Food distaste,
Ammonia odor to breath,
Mouth ulcerations and bleeding,
Constipation or diarrhea and
Bleeding from gastrointestinal tract.
BLOOD-FORMING SYSTEM :-
Anemia due to erythropoietin deficiency
PULMONARY SYSTEM:-
Fluid in the lungs with breathing
difficulties,
Thick sputum,
Uremic pneumonitis (inflammation of lung
tissue),
Pleuritic pain; shortness of breath
CARDIOVASCULAR SYSTEM:-
Chest pain due to inflammation of the sac
surrounding the heart (pericarditis) and
pericardial effusion (fluid accumulation
around the heart),
Hypertension,
Pitting edema,
Hyperkalemia and hyperlipidemia.
SKIN:-
Generalized itching (pruritus),
Dry,
Thin,brittle nails, and thin hairs.
Other Symptoms –
General ill feeling and fatigue
Weakness
Oliguria
Headache
Bone pain
Low level of sexual interest
CBC
IMAGING STUDIES:-
 Imaging tests (such as CT or ultrasound) may be
recommended to determine if there are any
obstructions (blockages) of the urinary tract,
kidney stones, or other abnormalities.
RENAL BIOPSY:-
 In a renal biopsy, a small piece of kidney tissue is
removed and analyzed. The biopsy helps to
identify abnormalities in kidney tissue that may
be the cause of renal failure
Treatment of chronic renal failure may
include dietary therapy such as a low
protein diet to limit the accumulation of
end products of protein metabolism that
the kidneys cannot excrete.
For patients on continuous peritoneal
dialysis, however a high protein diet is
recommended,
 For some patients, dietary restrictions are
also implemented. Sodium, potassium and
phosphate restrictions, for example, prevent
elevated levels of these minerals and fluid
restrictions help maintain fluid balance.
 Other measures include balanced fluid
intake, and monitoring weight changes, vital
signs, electrolyte balance, and cardiac and
mental status.
To treat hyperkalemia and fluid
imbalances dialysis may be performed.
 Drug therapy is commonly implemented as
well.
 To mobilize fluids that cause edema, loop
diuretics such as furosemide (Lasix) and
cardiac glycosides such as digoxin are used.
 Phosphate binders such as calcium carbonate
(caltrate) or calcium acetate (Phoslo) is
prescribed to treat renal osteodystrophy
(defective bone development) by binding
phosphate and supplementing calcium.
Blood pressure and edema are controlled
with antihypertensive agents.
Antiemetic are used to relieve nausea
and vomiting, ranitidine decrease gastric
irritation.
 Kidney transplant surgery is a procedure of
curing the patient with end- stage of renal
disease.
 A kidney transplant is a surgical procedure in
which a kidney is removed from one person
(donor) and placed into the body of a person
suffering from renal failure (recipient), in whom
the transplanted kidney can perform all the
functions which the patient’s own kidneys are
not able to perform.
Assessment:-
 Nurses may find some sign and symptom of
acute renal failure.
 There are many complain from patient related to
his / her condition such as; Anorexia, Nausea,
Vomiting,, Headache, diarrhea or constipation,
Irritability, Restlessness, Lethargy,, Thick
tenaciouse sputum, Urine output less than 400
ml/day for 1 to 2 weeks and then followed by
diuresis (3 to 5 L/day) for 2 to 3 weeks, Weight
gain
Determine if there is a history of cardiac
disease, malignancy, sepsis, or
intercurrent illness.
Determine if patient has been exposed to
potentially nephrotoxic drugs
(antibiotics, N SAIDs, contrast agents,
solvents).
Conduct an ongoing physical
examination for tissue turgor, pallor, and
alteration in mucous membranes, blood
pressure, heart rate changes, pulmonary
edema,and peripheral edema.
Monitor intake and output
 Fluid volume excess related to decreased
glomerular filtration rate or decreased urine
output or sodium retention as evidenced by
weight gain, edema, intake greater than
output,changes in urine specific gravity.
 GOAL:- Maintenance of normal fluid and
electrolyte level and proper body weight
without excess fluid and absence of edema.
Monitor weight daily at time; report gain
of greater than 2 pounds.
Record accurate intake and output. and
sodium levels Include hidden fluids, such
as IV antibiotic additives, liquid
medications, ice chips, and frozen treats.
Measure GI losses and estimate
insensible losses,such as diaphoresis
 Assess skin, face, and dependent areas for
edema. Evaluate degree of edema.
 Administer and restrict fluids, as indicated.
Maintain sodium and fluid restrictions as
ordered.
 Prepare for dialysis as indicated, such as
hemodialysis, peritoneal dialysis (PD), or
continuous renal replacement therapy
(CRRT)
Risk for infection related to depression of
immunologic defenses (secondary to
uraemia), invasive procedures/ devices
and changes in dietary intake /
malnutrition.
GOAL:- Preventing infection
Monitor for signs and symptoms of
infection and report promptly to
physician.
Protect patient from any source of
infection, including infected roommates,
visitors, or nursing staff.
Promote good hand washing by Client
and staff
 Avoid invasive procedures, instrumentation,
and manipulation of indwelling catheters. Use
aseptic technique When caring for IV and
invasive lines. Change site & dressings per
protocol.
 Provide routine catheter care and promote
meticulous perineal care. Keep urinary drainage
system closed and remove indwelling catheter as
soon as possible.
 Encourage deep breathing, coughing, and
frequent position changes
Teach patient and family signs and
symptoms of infection to report to
physician.
Administer antibiotic medications as
prescribed by the physician.
Obtain specimen(s) for culture and
sensitivity and administer appropriate
antibiotics as indicated.
Risk for decreased cardiac output related
to fluid overload, fluid shifts, fluid deficit
(excessive losses), and electrolyte
imbalance (potassium, calcium), severe
acidosis.
GOAL:- Maintaining adequate c a r d i a c
output
 Monitor blood pressure and adequate
cardiac output heart rate at regular
intervals.
 Observe electrocardiogram (ECG) or
telemetry for changes in rhythm;
 Assess colour of skin, mucous
membranes, and nail beds. Note capillary
refill time.
 Maintain bed rest or encourage adequate
rest and provide assistance with care and
desired activities.
 Provide supplemental oxygen if indicated.
 Note occurrence of slow pulse, hypotension,
flushing, nausea/vomiting, and depressed level
of consciousness.
 Investigate reports of muscle cramps,
numbness/ tingling of fingers, with muscle
twitching, hyperreflexia.
 Administer medications as indicated: Inotropic
agents; e.g digoxin (Lanoxin); Calcium
gluconate; Aluminum hydroxide gels
(Amphojel, Basalgel); Sodium bicarbonate or
sodium citrate; Sodium polystyrene sulfonate
(Kayexalate).

Contenu connexe

Tendances

Benign prostatic hyperplasia (bph)
Benign prostatic hyperplasia (bph)Benign prostatic hyperplasia (bph)
Benign prostatic hyperplasia (bph)
Ekta Patel
 
Benign Prostate Hypertrophy for nursing students
Benign Prostate Hypertrophy for nursing studentsBenign Prostate Hypertrophy for nursing students
Benign Prostate Hypertrophy for nursing students
Preeths Roshan
 

Tendances (20)

Cirrhosis of Liver
Cirrhosis of LiverCirrhosis of Liver
Cirrhosis of Liver
 
renal failure
renal failurerenal failure
renal failure
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Chronic Renal Failure (End Stage Renal Failure)
Chronic Renal Failure (End Stage Renal Failure)Chronic Renal Failure (End Stage Renal Failure)
Chronic Renal Failure (End Stage Renal Failure)
 
NEPHRITIS
NEPHRITISNEPHRITIS
NEPHRITIS
 
Renal Failure
Renal FailureRenal Failure
Renal Failure
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
 
Angina Pectoris
Angina PectorisAngina Pectoris
Angina Pectoris
 
Congestive cardiac failure
Congestive cardiac failureCongestive cardiac failure
Congestive cardiac failure
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
 
Benign prostatic hyperplasia (bph)
Benign prostatic hyperplasia (bph)Benign prostatic hyperplasia (bph)
Benign prostatic hyperplasia (bph)
 
Meningitis
MeningitisMeningitis
Meningitis
 
Urinary tract infection
Urinary tract infectionUrinary tract infection
Urinary tract infection
 
Acute and chronic renal failure
Acute and chronic renal failureAcute and chronic renal failure
Acute and chronic renal failure
 
Diabetes Insipidus
Diabetes Insipidus Diabetes Insipidus
Diabetes Insipidus
 
Benign Prostate Hypertrophy for nursing students
Benign Prostate Hypertrophy for nursing studentsBenign Prostate Hypertrophy for nursing students
Benign Prostate Hypertrophy for nursing students
 
Chronic renal failure (CRF)
Chronic renal failure (CRF)Chronic renal failure (CRF)
Chronic renal failure (CRF)
 
Ckd ppt
Ckd pptCkd ppt
Ckd ppt
 
Benign prostate hyperplasia (BPH)
Benign prostate hyperplasia (BPH) Benign prostate hyperplasia (BPH)
Benign prostate hyperplasia (BPH)
 
Liver cirrhosis
Liver cirrhosisLiver cirrhosis
Liver cirrhosis
 

Similaire à Acute renal failure and chronic renal failure

Urinary disorders watson
Urinary disorders  watsonUrinary disorders  watson
Urinary disorders watson
shenell delfin
 
Acute renal failure (1)
Acute renal failure (1)Acute renal failure (1)
Acute renal failure (1)
drsonumbbs
 
Acute renal failure.pptx
Acute renal failure.pptxAcute renal failure.pptx
Acute renal failure.pptx
SubhashreeMahapatro
 

Similaire à Acute renal failure and chronic renal failure (20)

ACUTE RENAL FAILURE OR ACUTE KIDNEY DISEASE
ACUTE RENAL FAILURE OR ACUTE KIDNEY DISEASEACUTE RENAL FAILURE OR ACUTE KIDNEY DISEASE
ACUTE RENAL FAILURE OR ACUTE KIDNEY DISEASE
 
Acute Kidney Injury.pptx
Acute Kidney Injury.pptxAcute Kidney Injury.pptx
Acute Kidney Injury.pptx
 
Chronic renal failure
Chronic renal failureChronic renal failure
Chronic renal failure
 
Acute renal failure.
Acute renal failure.Acute renal failure.
Acute renal failure.
 
Renal function
Renal functionRenal function
Renal function
 
Chronic kidney disease and its management
Chronic kidney disease and its managementChronic kidney disease and its management
Chronic kidney disease and its management
 
Acute renal failure
Acute   renal failureAcute   renal failure
Acute renal failure
 
Group 3 Fisher
Group 3 FisherGroup 3 Fisher
Group 3 Fisher
 
Acute renal failure
Acute renal failure Acute renal failure
Acute renal failure
 
Urinary disorders watson
Urinary disorders  watsonUrinary disorders  watson
Urinary disorders watson
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
Acute renal failure (1)
Acute renal failure (1)Acute renal failure (1)
Acute renal failure (1)
 
Acute renal failure.pptx
Acute renal failure.pptxAcute renal failure.pptx
Acute renal failure.pptx
 
Notes on renal failure
Notes on renal failureNotes on renal failure
Notes on renal failure
 
Kidney failure
Kidney failureKidney failure
Kidney failure
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
Acute renal failure by dr. rafique
Acute renal failure by dr. rafiqueAcute renal failure by dr. rafique
Acute renal failure by dr. rafique
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
AKI AND CKD
AKI AND CKDAKI AND CKD
AKI AND CKD
 
Hypernatremia
HypernatremiaHypernatremia
Hypernatremia
 

Plus de NEHA BHARTI

ANTI MALARIAL.pptx
ANTI MALARIAL.pptxANTI MALARIAL.pptx
ANTI MALARIAL.pptx
NEHA BHARTI
 
QUINOLONES.pptx
QUINOLONES.pptxQUINOLONES.pptx
QUINOLONES.pptx
NEHA BHARTI
 
sulfonamides.pptx
sulfonamides.pptxsulfonamides.pptx
sulfonamides.pptx
NEHA BHARTI
 
4. macrolide antibiotics.pptx
4. macrolide antibiotics.pptx4. macrolide antibiotics.pptx
4. macrolide antibiotics.pptx
NEHA BHARTI
 
3. aminoglycosides.pptx
3. aminoglycosides.pptx3. aminoglycosides.pptx
3. aminoglycosides.pptx
NEHA BHARTI
 
2. cephalosporins.ppt
2. cephalosporins.ppt2. cephalosporins.ppt
2. cephalosporins.ppt
NEHA BHARTI
 
CHEMOTHERAPY- PENICILLIN.pptx
CHEMOTHERAPY- PENICILLIN.pptxCHEMOTHERAPY- PENICILLIN.pptx
CHEMOTHERAPY- PENICILLIN.pptx
NEHA BHARTI
 

Plus de NEHA BHARTI (14)

ANTI MALARIAL.pptx
ANTI MALARIAL.pptxANTI MALARIAL.pptx
ANTI MALARIAL.pptx
 
QUINOLONES.pptx
QUINOLONES.pptxQUINOLONES.pptx
QUINOLONES.pptx
 
sulfonamides.pptx
sulfonamides.pptxsulfonamides.pptx
sulfonamides.pptx
 
4. macrolide antibiotics.pptx
4. macrolide antibiotics.pptx4. macrolide antibiotics.pptx
4. macrolide antibiotics.pptx
 
3. aminoglycosides.pptx
3. aminoglycosides.pptx3. aminoglycosides.pptx
3. aminoglycosides.pptx
 
2. cephalosporins.ppt
2. cephalosporins.ppt2. cephalosporins.ppt
2. cephalosporins.ppt
 
CHEMOTHERAPY- PENICILLIN.pptx
CHEMOTHERAPY- PENICILLIN.pptxCHEMOTHERAPY- PENICILLIN.pptx
CHEMOTHERAPY- PENICILLIN.pptx
 
Polycystic kidney disease
Polycystic kidney diseasePolycystic kidney disease
Polycystic kidney disease
 
Hydronephrosis
HydronephrosisHydronephrosis
Hydronephrosis
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
ABDELLAH’S THEORY
ABDELLAH’S THEORYABDELLAH’S THEORY
ABDELLAH’S THEORY
 
Nursing assessment and assessment of eye
Nursing assessment and assessment of eyeNursing assessment and assessment of eye
Nursing assessment and assessment of eye
 
Bowel elimination
Bowel eliminationBowel elimination
Bowel elimination
 

Dernier

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Dernier (20)

Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 

Acute renal failure and chronic renal failure

  • 1.
  • 2. HIBBs is a program of the Global Health Informatics Partnership PRESENTED BY: - NEHA BHARTI M.SC (N) MEDICAL SURGICAL NURSING NURSING TUTOR SMVDCON, KAKRYAL ACUTE RENAL FAILURE
  • 3.
  • 4.
  • 5. RENAL FAILURE  Renal failure or kidney failure (formerly called renal insufficiency) is a situation in which the kidneys fail to function adequately.  It is characterised by the reduction in the excretory and regulatory functions of the kidney.
  • 6.  If the kidney function fails, the waste products accumulate in the blood and the body leading to a disruption in endocrine and metabolic functions as well as fluid, electrolyte, and acidbase disturbances.  Renal failure can be acute, with sudden onset of symptoms, or chronic, occurring gradually over time.
  • 7.  Once renal failure occurs, it requires immediate management and even then prognosis is often not good unless transplantation is done.
  • 8.
  • 9. ACUTE RENAL FAILURE  Acute kidney failure is the sudden and complete loss of the ability of the kidneys to remove waste.  It occurs when the kidneys stop working over a period of hours, days, or in some cases, weeks.
  • 10. Acute kidney failure a sudden decline in renal function, usually marked by  Decreased glomerular filtration rate (GFR),  Increased concentrations of blood urea nitrogen (BUN; azotemia) and creatinine;  The urine output is less than 400 ml per day (oliguria);  Hyperkalemia (blood potassium level is normally 3.6 to 5.2 millimoles per liter (mmol/L)) and  Sodium retention.
  • 11.  Acute kidney failure is most common in people who are already hospitalized/ particularly in Critically ill people who need intensive care.
  • 12. ETIOLOGY AND CATEGORIES OF ACUTE RENAL FAILURE
  • 13.
  • 14. RISK FACTORS Acute kidney failure almost always occurs in connection with another medical condition or event. Conditions that increase risk of acute kidney failure include:  Being hospitalized, especially for a serious condition that requires intensive care  Advanced age
  • 15.  Blockages in the blood vessels in arms or legs (peripheral artery disease)  Diabetes  High blood pressure  Heart failure  Kidney diseases  Liver disease
  • 16. PATHOPHYSIOLOGY In response to renal injury, there is thought to be an increase in intra- glomerular pressure with glomerular hypertrophy, as the kidney attempts to adapt to nephron loss to maintain constant glomerular filtration Failure of renal circulation and glomerular or tubular dysfunction Damaged tubules cannot conserve sodium normally which activates rennin angiotensin– aldosterone system Pathogenesis of acute renal failure is not clear:
  • 17. Sodium and fluid retention which leads to edema Reduced blood flow to kidney due to renal vasoconstriction Sudden and complete loss of kidney function
  • 18. Oliguria Increased serum creatinine, BUN level and retention of other metabolic waste Increased circulatory overload and sodium retention ACUTE RENAL FAILURE
  • 20. 1. Onset or Initiation Phase  It marks the time from the onset of injury till the death of a person. ARF begins with the underlying clinical condition leading to tubular necrosis, for example haemorrhage, which reduces blood volume.  This period lasts from hours to days only but can cause irreversible damage
  • 21. 2. Oliguric Phase  This phase starts when urinary volume less than 30 ml to 400 ml/ 24 hours. A persistent decrease in GFR and tubular necrosis characterizes this phase.  This phase of acute renal failure lasts for 7-14 days but does a lot of damage to the walls and membranes of the kidney.
  • 22.  The period of oliguria accompanied by a rise in the urea, creatinine, uric acid, organic acid and intracellular cations (potassium and magnesium).
  • 23. 3. Diuresis Phase  Diuresis phase is marked by increased urine secretion of more than 400 ml/ 24 hours. Renal function of the kidney improves quickly the fifteen to twenty five days of this phase.  The patient is closely monitored for dehydration during this phase; if dehydration occurs, the uremic symptoms are likely to increase.
  • 24. 4. Recovery Phase  It begins with the recovery of the tubular function to such an extent that BUN and serum creatinine stabilizes.  Improvement in renal function may continue over 3 to 12 months and more nephrons regain function
  • 26. DARK COLORED URINE Foamy or bubbly urine and getting up at night to urinate
  • 27.  Skin and mucous membrane are dry from dehydration  Azotemia :- is a medical condition characterized by abnormally high levels of nitrogen-containing compounds (such as urea, creatinine, various body waste compounds, and other nitrogen-rich compounds) in the blood.  Oliguria or anuria: Less than 30cc (30ml) an hour urine output despite replacement.
  • 28.  Edema or Fluid retention, causing swelling in legs, ankles or feet  Hypertension and Rapid heart rate  Metabolic acidosis:- is a condition that occurs when the body produces excessive quantities of acid or when the kidneys are not removing enough acid from the body.
  • 29.  Anemia  Increased susceptibility to secondary infection  Fluid and electrolyte imbalance  Gastrointestinal System: Anorexia, nausea, vomiting, diarrhea or constipation, dry mucous membrane, abdominal pain and may have the odor of urine
  • 30. DIAGNOSTIC EVALUATIONS  Blood tests: elevated blood urea nitrogen (BUN), serum creatinine, and potassium level (hyperkalemia); decreased bicarbonate level, hematocrit and hemoglobin levels; and low blood pH.  Levels of BUN and creatinine are high in kidney failure. This is called azotemia.  Electrolyte levels in the blood may be abnormally high or low because of improper filtering.
  • 31.  Urine tests: Analyzing a sample of urine, a procedure called urinalysis, may reveal abnormalities that suggest kidney failure.  The amount of urine excrete in one day may help doctor determine the cause of kidney failure.  Urine studies shows proteinuria, hematuria, and decreased specific gravity.  Urine chemistry shows decreased amount of sodium (below 20 mEq/L) in urine and high potassium level.
  • 32. Imaging tests:  The diagnosis of ARF is also supported by ultrasonography, plain films of the abdomen, KUB radiography, renal scan, pyelography, computerized tomography.
  • 33. Kidney Biopsy:  In certain situations, doctor may recommend a kidney biopsy to remove a small sample of kidney tissue for laboratory testing.  To remove a sample of kidney tissue, doctor may insert a thin needle through skin and into kidney.
  • 34. MANAGEMENT  Treatment for acute kidney failure involves identifying the illness or injury that originally damaged kidneys.  Once the cause is found, the goal of treatment is to correct or treat the cause of kidney failure, restore kidney function and prevent fluid and waste from building up in the body while the kidneys heal.
  • 35. A. Pharmacologic Therapy  Drugs are used to reduce the blood pressure (antihypertensive); diuretics (drugs that increase urine output) are used.  Low dose dopamine (1-3g/kg) is often used to dilate the renal arteries through stimulation of dopaminergic receptors.  Diuretic therapy with furosemide or mannitol may be used for management of fluid volume status.
  • 36.  Calcium or glucose/insulin will be given through a vein to help avoid dangerous increases in blood potassium levels.  Administer intravenous sodium bicarbonate for more severe hyperkalemic symptoms and for the correction of acidosis and elevated phosphate level.
  • 37.  Antibiotics may be needed to treat associated infections (predominantly only antibiotics excreted by the liver are used if there is no liver disease (erythromycin, azithromycin, chloramphenicol).  Administer anticonvulsants (levetiracetam) for seizures (excessive and abnormal brain cell activity), antiemetics (drugs that prevent vomiting) for nausea, laxatives for constipation and vitamin supplements
  • 38. B. FLUID AND ELECTROLYTE REPLACEMENT  Intravenous solutions must be carefully selected according to the patient’s fluid and electrolyte status.  Treat hyperkalemia (high potassium) with insulin, calcium gluconate, Sodium polystyrene sulfonate or dialysis.
  • 39.  Replace lost fluids, such as water, blood, and plasma, and restore blood flow to the kidneys in cases of prerenal ARF caused by dehydration or blood loss, for example, kidney function may quickly return to normal after fluid and blood levels are corrected.
  • 40. C. Nutritional Therapy  Proper nutrition is crucial in the management of acute renal failure. A high calorie diet that’s low in protein, sodium and potassium is usually prescribed to meet the metabolic needs of patient in renal failure.  Potassium intake is usually restricted to 40 to 60mEq/day and sodium is usually restricted to 2g/day.  Low-potassium foods include apples, cabbage, carrots, green beans, grapes and strawberries.
  • 43. NURSING DIAGNOSIS 1. Fluid volume excess related to decreased glomerular filtration rate, decreased urine output and sodium retention as evidenced by weight gain, edema, intake greater than output, changes in urine specific gravity, jugular vein distention and shortness of breath; orthopnea. 2. Risk for decreased cardiac output related to fluid overload, fluid shifts, fluid deficit (excessive losses), and electrolyte imbalance (potassium, calcium),severe acidosis.
  • 44. 3. Imbalanced Nutrition: Less Than Body Requirements related to protein catabolism; dietary restrictions to reduce nitrogenous waste products, increased metabolic needs, anorexia, nausea, vomiting, dietary restriction and malnutrition associated with renal failure as evidenced by weakness and weight changes. 4. Risk for infection related to depression of immunologic defenses (secondary to uremia), invasive procedures/ devices and changes in dietary intake/malnutrition
  • 45. 5. Risk for deficient fluid volume related to excessive loss of fluid (diuretic phase of ARF, with rising urinary volume and delayed return of tubular re- absorption capabilities)
  • 46.
  • 48. Chronic kidney disease (CKD), also known as chronic renal disease, is a rapidly progressive deterioration or loss of renal function in which the body’s ability to maintain metabolic and fluid and electrolyte balance fails, resulting in uremia or azotemia over a period of months or years.
  • 49. This is characterized by a slow, insidious, and irreversible impairment of renal excretory and regulatory function. The final stage of chronic kidney disease is called endstage renal disease (ESRD).
  • 50. Chronic glomerulonephritis (inflammation of the glomeruli) Long term infection such as chronic pyelo- nephritis, and tuberculosis Nephrotoxic agents: Long term aminoglycoside therapy Autoimmune disorders (such as systemic lupus erythematosus and scleroderma) Kidney stones and infection
  • 51.
  • 52. Due to any etiological factors renal functions declines Nephron damage is progressive; damage nephron cannot function and do not recover Decreased GFR Remaining nephrons undergo changes to compensate for those damaged nephrons
  • 53. Compensatory excretion continues as GFR diminishes Filtration of more concentrated blood by the remaining nephrons Damage of nephron results in hypertrophy Urine may contain abnormal amount of protein, RBCs, WBCs
  • 54. Increased serum creatinine, BUN, urea and other nitrogenous waste in blood Further, damage of nephron 80-90% CHRONIC RENAL FAILURE
  • 55. 1. REDUCED RENAL RESERVE: Chronic renal failure is a progressive disease process.In the early,or silent, stage the patient is usually without symptoms,even though up to 50 percent of nephron function may have been lost.This stage is often not diagnosed.
  • 56. 2. RENAL INSUFFICIENCY:  The renal insufficiency stage occurs when the patient has lost 75 percent of nephron function and some signs of mild renal failure are present.  Anemia and the inability to concentrate urine may occur. The BUN and creatinine levels are slightly elevated. These patients are at risk for further damage caused by infection,dehydration, drugs,etc.
  • 57. The goal of care is to prevent further damage if possible by good control of blood sugar levels and blood pressure.
  • 58. 3. END-STAGE RENAL DISEASE:  ESRD occurs when 90 percent of the nephrons are lost. Patients at this stage experience chronic and persistent abnormal kidney function. The BUN and creatinine levels are always elevated.  These patients may make urine but not filter out the waste products, or urine production may cease. Dialysis or a kidney transplant is required to survive. Uremia (urea in the blood) is present in chronic renal failure.
  • 59. Patients eventually develop problems in all body systems.If left untreated,the patient with uremia dies,often within weeks
  • 60. Uremic symptoms can affect every organ system, most noticeably the following: NEUROLOGICAL SYSTEM:  Cognitive impairment,  Personality change,  Asterixis ( (tremer) motor disturbance that affects groups of muscles), seizures (rare), confusion,  Inability to concentrate, disorientation,  Burning of soles of feet
  • 61. GASTROINTESTINAL SYSTEM – Nausea,vomiting, Food distaste, Ammonia odor to breath, Mouth ulcerations and bleeding, Constipation or diarrhea and Bleeding from gastrointestinal tract.
  • 62. BLOOD-FORMING SYSTEM :- Anemia due to erythropoietin deficiency PULMONARY SYSTEM:- Fluid in the lungs with breathing difficulties, Thick sputum, Uremic pneumonitis (inflammation of lung tissue), Pleuritic pain; shortness of breath
  • 63. CARDIOVASCULAR SYSTEM:- Chest pain due to inflammation of the sac surrounding the heart (pericarditis) and pericardial effusion (fluid accumulation around the heart), Hypertension, Pitting edema, Hyperkalemia and hyperlipidemia.
  • 65. Other Symptoms – General ill feeling and fatigue Weakness Oliguria Headache Bone pain Low level of sexual interest
  • 66. CBC IMAGING STUDIES:-  Imaging tests (such as CT or ultrasound) may be recommended to determine if there are any obstructions (blockages) of the urinary tract, kidney stones, or other abnormalities. RENAL BIOPSY:-  In a renal biopsy, a small piece of kidney tissue is removed and analyzed. The biopsy helps to identify abnormalities in kidney tissue that may be the cause of renal failure
  • 67. Treatment of chronic renal failure may include dietary therapy such as a low protein diet to limit the accumulation of end products of protein metabolism that the kidneys cannot excrete. For patients on continuous peritoneal dialysis, however a high protein diet is recommended,
  • 68.  For some patients, dietary restrictions are also implemented. Sodium, potassium and phosphate restrictions, for example, prevent elevated levels of these minerals and fluid restrictions help maintain fluid balance.  Other measures include balanced fluid intake, and monitoring weight changes, vital signs, electrolyte balance, and cardiac and mental status.
  • 69. To treat hyperkalemia and fluid imbalances dialysis may be performed.
  • 70.  Drug therapy is commonly implemented as well.  To mobilize fluids that cause edema, loop diuretics such as furosemide (Lasix) and cardiac glycosides such as digoxin are used.  Phosphate binders such as calcium carbonate (caltrate) or calcium acetate (Phoslo) is prescribed to treat renal osteodystrophy (defective bone development) by binding phosphate and supplementing calcium.
  • 71. Blood pressure and edema are controlled with antihypertensive agents. Antiemetic are used to relieve nausea and vomiting, ranitidine decrease gastric irritation.
  • 72.  Kidney transplant surgery is a procedure of curing the patient with end- stage of renal disease.  A kidney transplant is a surgical procedure in which a kidney is removed from one person (donor) and placed into the body of a person suffering from renal failure (recipient), in whom the transplanted kidney can perform all the functions which the patient’s own kidneys are not able to perform.
  • 73. Assessment:-  Nurses may find some sign and symptom of acute renal failure.  There are many complain from patient related to his / her condition such as; Anorexia, Nausea, Vomiting,, Headache, diarrhea or constipation, Irritability, Restlessness, Lethargy,, Thick tenaciouse sputum, Urine output less than 400 ml/day for 1 to 2 weeks and then followed by diuresis (3 to 5 L/day) for 2 to 3 weeks, Weight gain
  • 74. Determine if there is a history of cardiac disease, malignancy, sepsis, or intercurrent illness. Determine if patient has been exposed to potentially nephrotoxic drugs (antibiotics, N SAIDs, contrast agents, solvents).
  • 75. Conduct an ongoing physical examination for tissue turgor, pallor, and alteration in mucous membranes, blood pressure, heart rate changes, pulmonary edema,and peripheral edema. Monitor intake and output
  • 76.  Fluid volume excess related to decreased glomerular filtration rate or decreased urine output or sodium retention as evidenced by weight gain, edema, intake greater than output,changes in urine specific gravity.  GOAL:- Maintenance of normal fluid and electrolyte level and proper body weight without excess fluid and absence of edema.
  • 77. Monitor weight daily at time; report gain of greater than 2 pounds. Record accurate intake and output. and sodium levels Include hidden fluids, such as IV antibiotic additives, liquid medications, ice chips, and frozen treats. Measure GI losses and estimate insensible losses,such as diaphoresis
  • 78.  Assess skin, face, and dependent areas for edema. Evaluate degree of edema.  Administer and restrict fluids, as indicated. Maintain sodium and fluid restrictions as ordered.  Prepare for dialysis as indicated, such as hemodialysis, peritoneal dialysis (PD), or continuous renal replacement therapy (CRRT)
  • 79. Risk for infection related to depression of immunologic defenses (secondary to uraemia), invasive procedures/ devices and changes in dietary intake / malnutrition. GOAL:- Preventing infection
  • 80. Monitor for signs and symptoms of infection and report promptly to physician. Protect patient from any source of infection, including infected roommates, visitors, or nursing staff. Promote good hand washing by Client and staff
  • 81.  Avoid invasive procedures, instrumentation, and manipulation of indwelling catheters. Use aseptic technique When caring for IV and invasive lines. Change site & dressings per protocol.  Provide routine catheter care and promote meticulous perineal care. Keep urinary drainage system closed and remove indwelling catheter as soon as possible.  Encourage deep breathing, coughing, and frequent position changes
  • 82. Teach patient and family signs and symptoms of infection to report to physician. Administer antibiotic medications as prescribed by the physician. Obtain specimen(s) for culture and sensitivity and administer appropriate antibiotics as indicated.
  • 83. Risk for decreased cardiac output related to fluid overload, fluid shifts, fluid deficit (excessive losses), and electrolyte imbalance (potassium, calcium), severe acidosis. GOAL:- Maintaining adequate c a r d i a c output
  • 84.  Monitor blood pressure and adequate cardiac output heart rate at regular intervals.  Observe electrocardiogram (ECG) or telemetry for changes in rhythm;  Assess colour of skin, mucous membranes, and nail beds. Note capillary refill time.  Maintain bed rest or encourage adequate rest and provide assistance with care and desired activities.  Provide supplemental oxygen if indicated.
  • 85.  Note occurrence of slow pulse, hypotension, flushing, nausea/vomiting, and depressed level of consciousness.  Investigate reports of muscle cramps, numbness/ tingling of fingers, with muscle twitching, hyperreflexia.  Administer medications as indicated: Inotropic agents; e.g digoxin (Lanoxin); Calcium gluconate; Aluminum hydroxide gels (Amphojel, Basalgel); Sodium bicarbonate or sodium citrate; Sodium polystyrene sulfonate (Kayexalate).